Nitric Oxide-Blocked Cross-Linked Tetrameric Hemoglobin

Patent No. EP2094292 (titled "Nitric Oxide-Blocked Cross-Linked Tetrameric Hemoglobin") was filed by Ikor on Oct 3, 2007. The application was issued on Jul 9, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FRANCESCO FELISATI INTERNAZIONALE BREVETTI INGG ZINIApr 1, 2015KLICZNIK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2094292

IKOR
Application Number
EP07843765A
Filing Date
Oct 3, 2007
Status
Revoked
Apr 15, 2019
Publication Date
Jul 9, 2014